Skip to main content
. 2002 Aug;46(8):2723–2726. doi: 10.1128/AAC.46.8.2723-2726.2002

TABLE 2.

Mean RI and change from baseline (± standard deviation)

Timepoint (parameter) Linezolid (n = 637) Comparators (n = 611) Adjusted difference 95% CI
Baseline
    Mean index 4.54 ± 2.38 4.62 ± 2.64 −0.06 −0.33 to 0.21
End of treatment
    Mean index 4.02 ± 2.28 5.42 ± 2.45 −1.43 −1.68 to −1.17
    Change from baseline −0.52 ± 2.52a 0.80 ± 2.54a −1.36 −1.63 to −1.09
Follow-up
    Mean index 5.84 ± 2.89 5.65 ± 2.64 0.25 −0.045 to 0.55
    Change from baseline 1.29 ± 2.58a 1.03 ± 2.64a 0.31 0.031 to 0.60
a

Change from baseline within treatment group (P < 0.01).